AVAX Technologies, Inc.

Research, Research, Biotechnology research
Founded in 1998
Philadelphia, Pennsylvania
http://www.avax-tech.com
None

About AVAX Technologies, Inc.

A pioneer in cancer vaccine development, AVAX Technologies, Inc. is an internationally integrated biotechnology company focused on developing and commercializing its AC Vaccine® technology for the treatment of cancer.Although subject to the same FDA regulations as other biological products, vaccines are inherently more difficult to develop, characterize, and manufacture than most pharmaceutical products. Vaccine development and commercialization is a long complex process. Avax is a leader in terms of stage of development and commercial readiness in the immuno-oncology arena. Today, the GMP approved facility is in Philadelphia and represents one of the very few autologous vaccine approved production facilities in the world.www.avax-tech.com

Company Metrics

  • Employees: 1-10
  • Monthly Visits: None
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue: Less than $1M
  • Total Funding: None None
  • Last Funding: None None (None)
  • Funding Status: None

Technology Stack

AVAX Technologies, Inc. actively uses None products in their tech stack.

Market Presence

Industries: Research, Research, Biotechnology research

Headquarters: Philadelphia, Pennsylvania